Rank | Gene Set | Z-score |
---|---|---|
1 | * eye photoreceptor cell development (GO:0042462) | 9.94368572 |
2 | retinal rod cell development (GO:0046548) | 9.32653188 |
3 | detection of light stimulus involved in sensory perception (GO:0050962) | 9.29879407 |
4 | detection of light stimulus involved in visual perception (GO:0050908) | 9.29879407 |
5 | phototransduction (GO:0007602) | 9.00315389 |
6 | phototransduction, visible light (GO:0007603) | 8.91717352 |
7 | GMP metabolic process (GO:0046037) | 8.61811808 |
8 | detection of visible light (GO:0009584) | 8.59068800 |
9 | detection of light stimulus (GO:0009583) | 8.55992617 |
10 | protein-chromophore linkage (GO:0018298) | 8.12857154 |
11 | visual perception (GO:0007601) | 7.86122825 |
12 | sensory perception of light stimulus (GO:0050953) | 7.78620321 |
13 | positive regulation of guanylate cyclase activity (GO:0031284) | 7.70913824 |
14 | photoreceptor cell differentiation (GO:0046530) | 7.47091821 |
15 | eye photoreceptor cell differentiation (GO:0001754) | 7.47091821 |
16 | regulation of guanylate cyclase activity (GO:0031282) | 6.86910372 |
17 | cellular response to light stimulus (GO:0071482) | 6.34823524 |
18 | detection of external stimulus (GO:0009581) | 6.03309436 |
19 | detection of abiotic stimulus (GO:0009582) | 5.95465867 |
20 | retina development in camera-type eye (GO:0060041) | 5.93954832 |
21 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.24293112 |
22 | nonmotile primary cilium assembly (GO:0035058) | 5.24004916 |
23 | regulation of cGMP metabolic process (GO:0030823) | 5.17521940 |
24 | presynaptic membrane assembly (GO:0097105) | 4.97429595 |
25 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.72315307 |
26 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.67062082 |
27 | retina layer formation (GO:0010842) | 4.50770204 |
28 | behavioral response to nicotine (GO:0035095) | 4.41758626 |
29 | regulation of cGMP biosynthetic process (GO:0030826) | 4.37568670 |
30 | positive regulation of cGMP metabolic process (GO:0030825) | 4.18426777 |
31 | cellular response to radiation (GO:0071478) | 4.16934472 |
32 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.12366101 |
33 | postsynaptic membrane organization (GO:0001941) | 4.12290878 |
34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.04961578 |
35 | sensory perception (GO:0007600) | 3.97670405 |
36 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.96190963 |
37 | gamma-aminobutyric acid transport (GO:0015812) | 3.92030332 |
38 | adaptation of signaling pathway (GO:0023058) | 3.88536893 |
39 | nucleobase catabolic process (GO:0046113) | 3.85720345 |
40 | protein localization to synapse (GO:0035418) | 3.80446953 |
41 | protein prenylation (GO:0018342) | 3.80123858 |
42 | prenylation (GO:0097354) | 3.80123858 |
43 | estrogen biosynthetic process (GO:0006703) | 3.78855895 |
44 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.74933584 |
45 | cell proliferation in forebrain (GO:0021846) | 3.52907211 |
46 | somite development (GO:0061053) | 3.48883760 |
47 | axoneme assembly (GO:0035082) | 3.46635310 |
48 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.46379548 |
49 | * neuron development (GO:0048666) | 3.45956319 |
50 | response to pheromone (GO:0019236) | 3.44792764 |
51 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.44358806 |
52 | protein polyglutamylation (GO:0018095) | 3.41521950 |
53 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.39707992 |
54 | positive regulation of mitochondrial fission (GO:0090141) | 3.36506526 |
55 | limb bud formation (GO:0060174) | 3.33079830 |
56 | response to light stimulus (GO:0009416) | 3.31398924 |
57 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.30737512 |
58 | sulfation (GO:0051923) | 3.29525428 |
59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.27141991 |
60 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.18509378 |
61 | indole-containing compound catabolic process (GO:0042436) | 3.16391660 |
62 | indolalkylamine catabolic process (GO:0046218) | 3.16391660 |
63 | tryptophan catabolic process (GO:0006569) | 3.16391660 |
64 | behavioral response to ethanol (GO:0048149) | 3.15336327 |
65 | retinal ganglion cell axon guidance (GO:0031290) | 3.14160767 |
66 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.12960501 |
67 | transmission of nerve impulse (GO:0019226) | 3.07550908 |
68 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.02174071 |
69 | membrane hyperpolarization (GO:0060081) | 3.01665408 |
70 | righting reflex (GO:0060013) | 3.01450963 |
71 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.00544923 |
72 | kynurenine metabolic process (GO:0070189) | 2.99700842 |
73 | startle response (GO:0001964) | 2.98952911 |
74 | spinal cord development (GO:0021510) | 2.98198450 |
75 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.96169140 |
76 | indolalkylamine metabolic process (GO:0006586) | 2.95673290 |
77 | regulation of action potential (GO:0098900) | 2.94665434 |
78 | negative regulation of mast cell activation (GO:0033004) | 2.94593398 |
79 | regulation of collateral sprouting (GO:0048670) | 2.94382296 |
80 | tryptophan metabolic process (GO:0006568) | 2.94340805 |
81 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.94007617 |
82 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.92803752 |
83 | regulation of timing of cell differentiation (GO:0048505) | 2.91227375 |
84 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.89339482 |
85 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.87059949 |
86 | NADH dehydrogenase complex assembly (GO:0010257) | 2.87059949 |
87 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.87059949 |
88 | regulation of penile erection (GO:0060405) | 2.86729687 |
89 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.85918958 |
90 | auditory behavior (GO:0031223) | 2.84251631 |
91 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.82930979 |
92 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.80789811 |
93 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79592951 |
94 | reflex (GO:0060004) | 2.79455390 |
95 | neuronal action potential (GO:0019228) | 2.79266238 |
96 | short-term memory (GO:0007614) | 2.79074151 |
97 | glycosphingolipid biosynthetic process (GO:0006688) | 2.77029410 |
98 | neural tube formation (GO:0001841) | 2.76906263 |
99 | neuronal action potential propagation (GO:0019227) | 2.76886490 |
100 | DNA deamination (GO:0045006) | 2.75542646 |
101 | mechanosensory behavior (GO:0007638) | 2.75227178 |
102 | olfactory bulb development (GO:0021772) | 2.74819396 |
103 | hippocampus development (GO:0021766) | 2.73549932 |
104 | retina homeostasis (GO:0001895) | 2.73274234 |
105 | response to histamine (GO:0034776) | 2.72830254 |
106 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.72805169 |
107 | fucose catabolic process (GO:0019317) | 2.72166354 |
108 | L-fucose metabolic process (GO:0042354) | 2.72166354 |
109 | L-fucose catabolic process (GO:0042355) | 2.72166354 |
110 | C4-dicarboxylate transport (GO:0015740) | 2.69208376 |
111 | glutamate receptor signaling pathway (GO:0007215) | 2.68067181 |
112 | regulation of cilium movement (GO:0003352) | 2.67131644 |
113 | dendritic spine morphogenesis (GO:0060997) | 2.67130617 |
114 | sympathetic nervous system development (GO:0048485) | 2.66291309 |
115 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.64662821 |
116 | forebrain neuron differentiation (GO:0021879) | 2.64007607 |
117 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.63441066 |
118 | epithelial cilium movement (GO:0003351) | 2.61065169 |
119 | synaptic transmission, glutamatergic (GO:0035249) | 2.60161288 |
120 | serotonin metabolic process (GO:0042428) | 2.59821668 |
121 | synaptic transmission, cholinergic (GO:0007271) | 2.59797008 |
122 | prostate gland growth (GO:0060736) | 2.58951690 |
123 | indole-containing compound metabolic process (GO:0042430) | 2.58306340 |
124 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.56264425 |
125 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.56264425 |
126 | regulation of neurotransmitter uptake (GO:0051580) | 2.56172777 |
127 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.55652088 |
128 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.54232516 |
129 | cornea development in camera-type eye (GO:0061303) | 2.53906023 |
130 | primary amino compound metabolic process (GO:1901160) | 2.52179892 |
131 | synapse assembly (GO:0007416) | 2.50598167 |
132 | dentate gyrus development (GO:0021542) | 2.50204300 |
133 | neuronal stem cell maintenance (GO:0097150) | 2.49145460 |
134 | presynaptic membrane organization (GO:0097090) | 2.48957323 |
135 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.48796667 |
136 | chemosensory behavior (GO:0007635) | 2.48501667 |
137 | appendage development (GO:0048736) | 2.47745510 |
138 | limb development (GO:0060173) | 2.47745510 |
139 | neuron cell-cell adhesion (GO:0007158) | 2.46476798 |
140 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.46373439 |
141 | embryonic epithelial tube formation (GO:0001838) | 2.44786675 |
142 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.43713880 |
143 | protein complex biogenesis (GO:0070271) | 2.43665097 |
144 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.43425226 |
145 | negative regulation of astrocyte differentiation (GO:0048712) | 2.40004259 |
146 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.38829118 |
147 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.38579182 |
148 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.38319570 |
149 | axon ensheathment in central nervous system (GO:0032291) | 2.37756624 |
150 | cilium organization (GO:0044782) | 2.37641454 |
151 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.32952001 |
152 | response to radiation (GO:0009314) | 2.31543773 |
153 | regulation of neurotransmitter secretion (GO:0046928) | 2.30975593 |
154 | lactate metabolic process (GO:0006089) | 2.29524018 |
155 | post-embryonic morphogenesis (GO:0009886) | 2.27014212 |
156 | retinoid metabolic process (GO:0001523) | 2.25796968 |
157 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.22712172 |
158 | axonal fasciculation (GO:0007413) | 2.22288237 |
159 | cilium assembly (GO:0042384) | 2.22173920 |
160 | protein heterotetramerization (GO:0051290) | 2.21550176 |
161 | calcium ion import (GO:0070509) | 2.18665013 |
162 | synaptic vesicle maturation (GO:0016188) | 2.17555862 |
163 | neuron recognition (GO:0008038) | 2.16801739 |
164 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.16728073 |
165 | regulation of development, heterochronic (GO:0040034) | 2.14772095 |
166 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.14441665 |
167 | regulation of dopamine metabolic process (GO:0042053) | 2.14332145 |
168 | regulation of catecholamine metabolic process (GO:0042069) | 2.14332145 |
169 | histone H3-K4 trimethylation (GO:0080182) | 2.13977465 |
170 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.13367088 |
171 | protein localization to cilium (GO:0061512) | 2.13107114 |
172 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.12378447 |
173 | dopamine receptor signaling pathway (GO:0007212) | 2.12253581 |
174 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 15.6050932 |
175 | rhodopsin mediated signaling pathway (GO:0016056) | 15.2670207 |
176 | retinal cone cell development (GO:0046549) | 12.4625673 |
177 | photoreceptor cell maintenance (GO:0045494) | 11.1034368 |
178 | * photoreceptor cell development (GO:0042461) | 10.5195697 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.86492362 |
2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.13808788 |
3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.91003275 |
4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.80868369 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.73492640 |
6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.41019228 |
7 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.23246591 |
8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22660310 |
9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.21302776 |
10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.12697316 |
11 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.11967230 |
12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.07999352 |
13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.05950476 |
14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03592227 |
15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.02718872 |
16 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.01674405 |
17 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.00723322 |
18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.99873338 |
19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.99464849 |
20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.92333092 |
21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92004522 |
22 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.90409729 |
23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87979992 |
24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.86610198 |
25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86504699 |
26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86504699 |
27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.86213739 |
28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.83423298 |
29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.83316302 |
30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.80652457 |
31 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.79762171 |
32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.79393480 |
33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.77730735 |
34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.75083129 |
35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73909055 |
36 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73817433 |
37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73757259 |
38 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.70938353 |
39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68559323 |
40 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.67305891 |
41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.64401145 |
42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63972430 |
43 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.63657936 |
44 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.63244986 |
45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60125574 |
46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59948925 |
47 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.59351599 |
48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56718001 |
49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55860713 |
50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52455804 |
51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51823994 |
52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51281192 |
53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49170143 |
54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49064114 |
55 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.48880229 |
56 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.48461128 |
57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.46980971 |
58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46808800 |
59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44995786 |
60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44564559 |
61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44140098 |
62 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.43476203 |
63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.43221706 |
64 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.41840417 |
65 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.41588139 |
66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.39069085 |
67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.37880275 |
68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36149224 |
69 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.35458100 |
70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.35112472 |
71 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34518459 |
72 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.34271661 |
73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.34271661 |
74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33813303 |
75 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.32743425 |
76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32478097 |
77 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.32283134 |
78 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.31346374 |
79 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.29186658 |
80 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28755782 |
81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28594227 |
82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25936508 |
83 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25918000 |
84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24778371 |
85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24638888 |
86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24638888 |
87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23877736 |
88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22089385 |
89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21842118 |
90 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.20112942 |
91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19726073 |
92 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18686145 |
93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18664652 |
94 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18050318 |
95 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17576024 |
96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17458755 |
97 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.17170918 |
98 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14809532 |
99 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.14720207 |
100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.14618083 |
101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14324610 |
102 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14307821 |
103 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13969957 |
104 | AR_19668381_ChIP-Seq_PC3_Human | 1.13922174 |
105 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13687258 |
106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13463824 |
107 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.12501220 |
108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12492654 |
109 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11541159 |
110 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10512744 |
111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10185219 |
112 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10126766 |
113 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09992090 |
114 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08059371 |
115 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.07289852 |
116 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.06730737 |
117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06670970 |
118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06560185 |
119 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.06483556 |
120 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06244650 |
121 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06195117 |
122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06098245 |
123 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.05707978 |
124 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05412630 |
125 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.05057546 |
126 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04408250 |
127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.04183785 |
128 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04096403 |
129 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02720603 |
130 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02343000 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003011_delayed_dark_adaptation | 9.12117815 |
2 | MP0005551_abnormal_eye_electrophysiolog | 8.75035551 |
3 | MP0006072_abnormal_retinal_apoptosis | 5.99098282 |
4 | * MP0005253_abnormal_eye_physiology | 5.96561915 |
5 | * MP0005195_abnormal_posterior_eye | 3.54808570 |
6 | MP0002638_abnormal_pupillary_reflex | 3.38894523 |
7 | MP0001324_abnormal_eye_pigmentation | 3.33123023 |
8 | MP0005423_abnormal_somatic_nervous | 3.32627231 |
9 | MP0003950_abnormal_plasma_membrane | 3.32243344 |
10 | * MP0005391_vision/eye_phenotype | 2.91474440 |
11 | MP0002229_neurodegeneration | 2.41977448 |
12 | MP0002090_abnormal_vision | 2.41792071 |
13 | MP0002653_abnormal_ependyma_morphology | 2.34082680 |
14 | MP0006292_abnormal_olfactory_placode | 2.18876807 |
15 | MP0000049_abnormal_middle_ear | 2.12324761 |
16 | * MP0002752_abnormal_somatic_nervous | 2.04408409 |
17 | MP0001986_abnormal_taste_sensitivity | 1.90191746 |
18 | MP0001485_abnormal_pinna_reflex | 1.86751703 |
19 | MP0002102_abnormal_ear_morphology | 1.74672321 |
20 | MP0002751_abnormal_autonomic_nervous | 1.68304698 |
21 | MP0001502_abnormal_circadian_rhythm | 1.66678728 |
22 | MP0003880_abnormal_central_pattern | 1.62283697 |
23 | * MP0002882_abnormal_neuron_morphology | 1.54747479 |
24 | MP0002837_dystrophic_cardiac_calcinosis | 1.53395484 |
25 | MP0005171_absent_coat_pigmentation | 1.52482718 |
26 | MP0004133_heterotaxia | 1.50786100 |
27 | MP0001486_abnormal_startle_reflex | 1.44413141 |
28 | MP0001984_abnormal_olfaction | 1.41730704 |
29 | MP0003119_abnormal_digestive_system | 1.41344555 |
30 | MP0008877_abnormal_DNA_methylation | 1.39756567 |
31 | MP0002160_abnormal_reproductive_system | 1.34608886 |
32 | MP0008872_abnormal_physiological_respon | 1.33009559 |
33 | MP0005367_renal/urinary_system_phenotyp | 1.27685770 |
34 | MP0000516_abnormal_urinary_system | 1.27685770 |
35 | MP0002822_catalepsy | 1.21811520 |
36 | MP0005646_abnormal_pituitary_gland | 1.20386957 |
37 | MP0003938_abnormal_ear_development | 1.16948303 |
38 | MP0005394_taste/olfaction_phenotype | 1.16515245 |
39 | MP0005499_abnormal_olfactory_system | 1.16515245 |
40 | MP0004885_abnormal_endolymph | 1.13016076 |
41 | MP0008789_abnormal_olfactory_epithelium | 1.12588732 |
42 | MP0004270_analgesia | 1.09412785 |
43 | MP0003937_abnormal_limbs/digits/tail_de | 1.09032668 |
44 | MP0005670_abnormal_white_adipose | 1.07732690 |
45 | MP0009046_muscle_twitch | 1.06569334 |
46 | MP0010386_abnormal_urinary_bladder | 1.06017343 |
47 | MP0002938_white_spotting | 1.04951027 |
48 | MP0000631_abnormal_neuroendocrine_gland | 1.02250728 |
49 | * MP0001764_abnormal_homeostasis | 1.00206333 |
50 | MP0000778_abnormal_nervous_system | 0.99958079 |
51 | MP0004019_abnormal_vitamin_homeostasis | 0.99195198 |
52 | MP0005389_reproductive_system_phenotype | 0.98753676 |
53 | MP0005645_abnormal_hypothalamus_physiol | 0.97648774 |
54 | MP0002095_abnormal_skin_pigmentation | 0.97372778 |
55 | MP0004859_abnormal_synaptic_plasticity | 0.95744728 |
56 | MP0005197_abnormal_uvea_morphology | 0.95461021 |
57 | MP0002282_abnormal_trachea_morphology | 0.93101924 |
58 | MP0003635_abnormal_synaptic_transmissio | 0.92897948 |
59 | MP0002272_abnormal_nervous_system | 0.90592394 |
60 | MP0002064_seizures | 0.90297844 |
61 | MP0002909_abnormal_adrenal_gland | 0.90140105 |
62 | MP0003646_muscle_fatigue | 0.89679921 |
63 | MP0002233_abnormal_nose_morphology | 0.89590211 |
64 | MP0003195_calcinosis | 0.88362431 |
65 | MP0001963_abnormal_hearing_physiology | 0.88295731 |
66 | MP0006276_abnormal_autonomic_nervous | 0.88203235 |
67 | MP0004742_abnormal_vestibular_system | 0.87740974 |
68 | MP0002734_abnormal_mechanical_nocicepti | 0.87295184 |
69 | MP0000026_abnormal_inner_ear | 0.87246033 |
70 | MP0001188_hyperpigmentation | 0.86688969 |
71 | MP0001968_abnormal_touch/_nociception | 0.86293375 |
72 | MP0003283_abnormal_digestive_organ | 0.86159615 |
73 | MP0009250_abnormal_appendicular_skeleto | 0.85775818 |
74 | MP0002063_abnormal_learning/memory/cond | 0.85139579 |
75 | MP0009053_abnormal_anal_canal | 0.84697973 |
76 | MP0001286_abnormal_eye_development | 0.84268239 |
77 | MP0005248_abnormal_Harderian_gland | 0.83557805 |
78 | MP0000566_synostosis | 0.82469080 |
79 | MP0002572_abnormal_emotion/affect_behav | 0.82122652 |
80 | MP0005084_abnormal_gallbladder_morpholo | 0.81192802 |
81 | MP0003121_genomic_imprinting | 0.80673706 |
82 | MP0009745_abnormal_behavioral_response | 0.80160911 |
83 | MP0002067_abnormal_sensory_capabilities | 0.79196069 |
84 | MP0000647_abnormal_sebaceous_gland | 0.78730146 |
85 | MP0000013_abnormal_adipose_tissue | 0.77842528 |
86 | MP0002184_abnormal_innervation | 0.74513242 |
87 | MP0001346_abnormal_lacrimal_gland | 0.71898229 |
88 | MP0003787_abnormal_imprinting | 0.69690915 |
89 | MP0004233_abnormal_muscle_weight | 0.68685697 |
90 | MP0003890_abnormal_embryonic-extraembry | 0.66647294 |
91 | MP0002557_abnormal_social/conspecific_i | 0.65505156 |
92 | * MP0003634_abnormal_glial_cell | 0.65298254 |
93 | MP0005187_abnormal_penis_morphology | 0.64120727 |
94 | MP0002127_abnormal_cardiovascular_syste | 0.64042084 |
95 | MP0005386_behavior/neurological_phenoty | 0.63327064 |
96 | MP0004924_abnormal_behavior | 0.63327064 |
97 | MP0002332_abnormal_exercise_endurance | 0.61416313 |
98 | MP0002277_abnormal_respiratory_mucosa | 0.58302470 |
99 | MP0004142_abnormal_muscle_tone | 0.57126633 |
100 | MP0010030_abnormal_orbit_morphology | 0.55856807 |
101 | MP0008995_early_reproductive_senescence | 0.55584764 |
102 | MP0004782_abnormal_surfactant_physiolog | 0.54085381 |
103 | MP0002152_abnormal_brain_morphology | 0.48609118 |
104 | MP0001905_abnormal_dopamine_level | 0.46436741 |
105 | MP0001970_abnormal_pain_threshold | 0.45206630 |
106 | MP0003136_yellow_coat_color | 0.44817120 |
107 | MP0002736_abnormal_nociception_after | 0.44417239 |
108 | MP0002066_abnormal_motor_capabilities/c | 0.43896042 |
109 | MP0000955_abnormal_spinal_cord | 0.42752322 |
110 | MP0005379_endocrine/exocrine_gland_phen | 0.42195908 |
111 | MP0001440_abnormal_grooming_behavior | 0.40839973 |
112 | MP0008004_abnormal_stomach_pH | 0.40376051 |
113 | MP0000569_abnormal_digit_pigmentation | 0.39024332 |
114 | MP0008569_lethality_at_weaning | 0.38920256 |
115 | MP0002735_abnormal_chemical_nociception | 0.38583035 |
116 | MP0000462_abnormal_digestive_system | 0.38571503 |
117 | MP0002234_abnormal_pharynx_morphology | 0.37844355 |
118 | MP0001501_abnormal_sleep_pattern | 0.37411770 |
119 | MP0003137_abnormal_impulse_conducting | 0.36437799 |
120 | MP0003698_abnormal_male_reproductive | 0.35340601 |
121 | MP0004085_abnormal_heartbeat | 0.35237050 |
122 | MP0002697_abnormal_eye_size | 0.34072837 |
123 | MP0002876_abnormal_thyroid_physiology | 0.33523872 |
124 | MP0004811_abnormal_neuron_physiology | 0.33285304 |
125 | MP0003861_abnormal_nervous_system | 0.32946111 |
126 | MP0005310_abnormal_salivary_gland | 0.32414223 |
127 | MP0001529_abnormal_vocalization | 0.32401183 |
128 | MP0003122_maternal_imprinting | 0.31710018 |
129 | MP0002733_abnormal_thermal_nociception | 0.31590827 |
130 | MP0008260_abnormal_autophagy | 0.31500710 |
131 | MP0004145_abnormal_muscle_electrophysio | 0.29034227 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Pigmentary retinal degeneration (HP:0001146) | 8.33855251 |
2 | Central scotoma (HP:0000603) | 7.87782879 |
3 | * Chorioretinal atrophy (HP:0000533) | 7.76707962 |
4 | Dyschromatopsia (HP:0007641) | 7.73036198 |
5 | Abnormality of macular pigmentation (HP:0008002) | 7.45714346 |
6 | Attenuation of retinal blood vessels (HP:0007843) | 7.27815272 |
7 | Scotoma (HP:0000575) | 7.10679966 |
8 | * Pendular nystagmus (HP:0012043) | 6.66768816 |
9 | Decreased central vision (HP:0007663) | 6.48997539 |
10 | * Abolished electroretinogram (ERG) (HP:0000550) | 6.16319150 |
11 | * Photophobia (HP:0000613) | 5.39970423 |
12 | * Type II diabetes mellitus (HP:0005978) | 5.30460597 |
13 | Cone-rod dystrophy (HP:0000548) | 4.97772110 |
14 | Severe visual impairment (HP:0001141) | 4.96272237 |
15 | Macular degeneration (HP:0000608) | 4.84632327 |
16 | Posterior subcapsular cataract (HP:0007787) | 4.46996961 |
17 | Constricted visual fields (HP:0001133) | 4.46651869 |
18 | Choroideremia (HP:0001139) | 4.28857709 |
19 | * Retinitis pigmentosa (HP:0000510) | 4.24996240 |
20 | * Keratoconus (HP:0000563) | 4.16623280 |
21 | * Increased corneal curvature (HP:0100692) | 4.16623280 |
22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.49404870 |
23 | Short 1st metacarpal (HP:0010034) | 3.23731786 |
24 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.23731786 |
25 | Progressive visual loss (HP:0000529) | 3.07033464 |
26 | Gait imbalance (HP:0002141) | 2.97966792 |
27 | Congenital primary aphakia (HP:0007707) | 2.93653151 |
28 | Abnormality of the 1st metacarpal (HP:0010009) | 2.85067493 |
29 | Retinal atrophy (HP:0001105) | 2.83221645 |
30 | Congenital sensorineural hearing impairment (HP:0008527) | 2.80616381 |
31 | Subcapsular cataract (HP:0000523) | 2.80246064 |
32 | Nephrogenic diabetes insipidus (HP:0009806) | 2.73276006 |
33 | Medial flaring of the eyebrow (HP:0010747) | 2.73173970 |
34 | Optic disc pallor (HP:0000543) | 2.62519796 |
35 | Stenosis of the external auditory canal (HP:0000402) | 2.60345138 |
36 | Type II lissencephaly (HP:0007260) | 2.58805285 |
37 | Oligodactyly (hands) (HP:0001180) | 2.53935787 |
38 | Intestinal atresia (HP:0011100) | 2.52967475 |
39 | Abnormality of the renal cortex (HP:0011035) | 2.48502257 |
40 | Focal seizures (HP:0007359) | 2.46497692 |
41 | Hemiparesis (HP:0001269) | 2.45703475 |
42 | True hermaphroditism (HP:0010459) | 2.42126698 |
43 | Short phalanx of the thumb (HP:0009660) | 2.39019920 |
44 | Gaze-evoked nystagmus (HP:0000640) | 2.38284208 |
45 | * Wide nasal bridge (HP:0000431) | 2.34268965 |
46 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.32669773 |
47 | * Vitreoretinal degeneration (HP:0000655) | 2.29218780 |
48 | Poor coordination (HP:0002370) | 2.24225139 |
49 | Vaginal atresia (HP:0000148) | 2.21510773 |
50 | Pancreatic fibrosis (HP:0100732) | 2.20928423 |
51 | Ectopic kidney (HP:0000086) | 2.19212689 |
52 | Genital tract atresia (HP:0001827) | 2.17500657 |
53 | Thyroid-stimulating hormone excess (HP:0002925) | 2.16369941 |
54 | Acute necrotizing encephalopathy (HP:0006965) | 2.08113762 |
55 | Hyperglycinemia (HP:0002154) | 2.07771824 |
56 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.06161621 |
57 | Cerebellar dysplasia (HP:0007033) | 2.05054438 |
58 | Renal hypoplasia (HP:0000089) | 2.02957961 |
59 | Pachygyria (HP:0001302) | 2.01975990 |
60 | Lissencephaly (HP:0001339) | 2.00106383 |
61 | 3-Methylglutaconic aciduria (HP:0003535) | 2.00008626 |
62 | Congenital stationary night blindness (HP:0007642) | 13.2312685 |
63 | * Bony spicule pigmentary retinopathy (HP:0007737) | 10.5381895 |
64 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.3966986 |
65 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.0820918 |
66 | Renal cortical cysts (HP:0000803) | 1.99907421 |
67 | Retinal dysplasia (HP:0007973) | 1.99592870 |
68 | Adactyly (HP:0009776) | 1.98083903 |
69 | Absent speech (HP:0001344) | 1.96982825 |
70 | Methylmalonic acidemia (HP:0002912) | 1.96386865 |
71 | Progressive macrocephaly (HP:0004481) | 1.94581831 |
72 | Tented upper lip vermilion (HP:0010804) | 1.93121711 |
73 | Action tremor (HP:0002345) | 1.90440933 |
74 | Thyroiditis (HP:0100646) | 1.90370796 |
75 | Drooling (HP:0002307) | 1.90070614 |
76 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.87275324 |
77 | Hypoplasia of the fovea (HP:0007750) | 1.87275324 |
78 | Severe muscular hypotonia (HP:0006829) | 1.85899144 |
79 | Abnormality of alanine metabolism (HP:0010916) | 1.84868781 |
80 | Hyperalaninemia (HP:0003348) | 1.84868781 |
81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84868781 |
82 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.84797514 |
83 | Abnormality of the labia minora (HP:0012880) | 1.83466674 |
84 | Abnormality of the fovea (HP:0000493) | 1.83001019 |
85 | Rib fusion (HP:0000902) | 1.82717898 |
86 | Abnormality of the renal collecting system (HP:0004742) | 1.81936433 |
87 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.81915781 |
88 | Febrile seizures (HP:0002373) | 1.80997662 |
89 | Pancreatic cysts (HP:0001737) | 1.80564267 |
90 | Polydipsia (HP:0001959) | 1.79939285 |
91 | Abnormal drinking behavior (HP:0030082) | 1.79939285 |
92 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.78290851 |
93 | Morphological abnormality of the middle ear (HP:0008609) | 1.77951908 |
94 | Tachypnea (HP:0002789) | 1.77842592 |
95 | Oligodactyly (HP:0012165) | 1.75356874 |
96 | Synostosis of carpal bones (HP:0005048) | 1.75241942 |
97 | Short hallux (HP:0010109) | 1.74169531 |
98 | Disproportionate short-trunk short stature (HP:0003521) | 1.73971457 |
99 | Acute encephalopathy (HP:0006846) | 1.73094644 |
100 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.72373638 |
101 | Colon cancer (HP:0003003) | 1.72209479 |
102 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.71336852 |
103 | Mitochondrial inheritance (HP:0001427) | 1.70345315 |
104 | Aganglionic megacolon (HP:0002251) | 1.69939165 |
105 | Dialeptic seizures (HP:0011146) | 1.69543973 |
106 | Epileptic encephalopathy (HP:0200134) | 1.61528922 |
107 | Astigmatism (HP:0000483) | 1.58797966 |
108 | * Optic atrophy (HP:0000648) | 1.54006637 |
109 | Cystic liver disease (HP:0006706) | 1.49578129 |
110 | Severe Myopia (HP:0011003) | 1.47736979 |
111 | Polar cataract (HP:0010696) | 1.46732608 |
112 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.44442715 |
113 | Horizontal nystagmus (HP:0000666) | 1.38582776 |
114 | Chorioretinal coloboma (HP:0000567) | 1.38446229 |
115 | Sclerocornea (HP:0000647) | 1.37262276 |
116 | Abnormality of midbrain morphology (HP:0002418) | 1.35093686 |
117 | Molar tooth sign on MRI (HP:0002419) | 1.35093686 |
118 | Septo-optic dysplasia (HP:0100842) | 1.34293493 |
119 | Progressive cerebellar ataxia (HP:0002073) | 1.30722183 |
120 | Specific learning disability (HP:0001328) | 1.30350492 |
121 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.26519297 |
122 | Asthma (HP:0002099) | 1.24102702 |
123 | Broad foot (HP:0001769) | 1.22023945 |
124 | Nephronophthisis (HP:0000090) | 1.21120171 |
125 | Dysdiadochokinesis (HP:0002075) | 1.17377816 |
126 | Chronic hepatic failure (HP:0100626) | 1.17326906 |
127 | Preaxial hand polydactyly (HP:0001177) | 1.17065117 |
128 | Recurrent sinusitis (HP:0011108) | 1.14900383 |
129 | Anencephaly (HP:0002323) | 1.14661372 |
130 | Retinal detachment (HP:0000541) | 1.14390029 |
131 | Congenital hepatic fibrosis (HP:0002612) | 1.12656710 |
132 | Postaxial foot polydactyly (HP:0001830) | 1.12642472 |
133 | Abnormality of the renal medulla (HP:0100957) | 1.10749337 |
134 | Postaxial hand polydactyly (HP:0001162) | 1.10462978 |
135 | Broad-based gait (HP:0002136) | 1.09714918 |
136 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.09020353 |
137 | Left ventricular hypertrophy (HP:0001712) | 1.08817823 |
138 | Interstitial pulmonary disease (HP:0006530) | 1.08405061 |
139 | Hyperventilation (HP:0002883) | 1.05397941 |
140 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.05328773 |
141 | Absent/shortened dynein arms (HP:0200106) | 1.04180331 |
142 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.04180331 |
143 | Male pseudohermaphroditism (HP:0000037) | 1.04056389 |
144 | Focal motor seizures (HP:0011153) | 1.02446932 |
145 | Short foot (HP:0001773) | 1.01371965 |
146 | Abnormality of the parathyroid morphology (HP:0011766) | 1.01036085 |
147 | Decreased testicular size (HP:0008734) | 1.00501036 |
148 | Osteomalacia (HP:0002749) | 0.99634049 |
149 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 0.99574331 |
150 | Optic nerve hypoplasia (HP:0000609) | 0.97657714 |
151 | Abnormal ciliary motility (HP:0012262) | 0.95799883 |
152 | Anophthalmia (HP:0000528) | 0.92676322 |
153 | Visual hallucinations (HP:0002367) | 0.91671642 |
154 | Midline defect of the nose (HP:0004122) | 0.90773895 |
155 | Dental crowding (HP:0000678) | 0.90110706 |
156 | Hypodontia (HP:0000668) | 0.89944589 |
157 | Genetic anticipation (HP:0003743) | 0.89303476 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GRK1 | 8.38052431 |
2 | PBK | 5.14826227 |
3 | FRK | 4.17237821 |
4 | IRAK2 | 2.82625137 |
5 | MAP4K2 | 2.71983478 |
6 | CASK | 2.63962997 |
7 | BRD4 | 2.22478327 |
8 | SIK3 | 2.18972150 |
9 | SIK2 | 2.16262275 |
10 | PINK1 | 2.12331451 |
11 | EPHA3 | 2.09859336 |
12 | MARK1 | 1.94287205 |
13 | MAP2K7 | 1.78732135 |
14 | CSNK1G2 | 1.76601177 |
15 | CSNK1G3 | 1.60238369 |
16 | INSRR | 1.59323767 |
17 | CDK19 | 1.54867626 |
18 | PRPF4B | 1.47053374 |
19 | CSNK1G1 | 1.45578801 |
20 | OXSR1 | 1.45357069 |
21 | CSNK1A1L | 1.45233706 |
22 | MAP3K4 | 1.43302020 |
23 | SGK223 | 1.42810122 |
24 | SGK494 | 1.42810122 |
25 | ADRBK1 | 1.41630427 |
26 | NTRK2 | 1.39873015 |
27 | NEK6 | 1.32802047 |
28 | TRIM28 | 1.31548493 |
29 | SGK2 | 1.30642597 |
30 | TNIK | 1.30480852 |
31 | MAPK13 | 1.27735841 |
32 | BCKDK | 1.27104140 |
33 | NUAK1 | 1.26171029 |
34 | TLK1 | 1.23108693 |
35 | ERBB2 | 1.16542963 |
36 | AKT3 | 1.14930120 |
37 | DYRK1A | 1.12255372 |
38 | TAF1 | 1.11148499 |
39 | PAK6 | 1.10107353 |
40 | VRK1 | 1.09408225 |
41 | STK39 | 1.08636766 |
42 | WNK4 | 1.06717149 |
43 | HIPK2 | 1.03875738 |
44 | BMPR1B | 1.03469809 |
45 | CDK3 | 1.02818315 |
46 | ACVR1B | 1.01922179 |
47 | DAPK2 | 1.01038811 |
48 | CAMK1G | 0.95220476 |
49 | BCR | 0.93078691 |
50 | BMPR2 | 0.92711469 |
51 | TAOK3 | 0.92420868 |
52 | MUSK | 0.91971013 |
53 | NTRK3 | 0.89809206 |
54 | PHKG1 | 0.87580253 |
55 | PHKG2 | 0.87580253 |
56 | MAPK7 | 0.87497545 |
57 | PAK3 | 0.87289678 |
58 | PLK2 | 0.85804132 |
59 | IRAK1 | 0.85320817 |
60 | PKN1 | 0.84700883 |
61 | PRKCZ | 0.82341197 |
62 | DYRK3 | 0.81211389 |
63 | LATS1 | 0.80065151 |
64 | YES1 | 0.79664885 |
65 | MKNK2 | 0.79563775 |
66 | ADRBK2 | 0.79323209 |
67 | MAPK12 | 0.77815643 |
68 | UHMK1 | 0.77187586 |
69 | CSNK1D | 0.76288006 |
70 | CAMK2A | 0.69536171 |
71 | MAP3K6 | 0.69002475 |
72 | PNCK | 0.66806826 |
73 | STK16 | 0.64437359 |
74 | EPHB2 | 0.61933371 |
75 | PRKCE | 0.61647208 |
76 | SGK3 | 0.60793105 |
77 | SGK1 | 0.60519884 |
78 | KSR1 | 0.59233213 |
79 | MKNK1 | 0.58855008 |
80 | PRKCB | 0.58119078 |
81 | PLK4 | 0.57791779 |
82 | CAMK1D | 0.56729699 |
83 | CDC7 | 0.56719566 |
84 | CSNK1A1 | 0.56176905 |
85 | GRK5 | 0.55995651 |
86 | CAMK2D | 0.55623171 |
87 | TGFBR1 | 0.54896147 |
88 | SRPK1 | 0.54188683 |
89 | DYRK2 | 0.53324833 |
90 | ZAK | 0.53305284 |
91 | FGFR2 | 0.53088362 |
92 | RPS6KA5 | 0.51848133 |
93 | CDK5 | 0.51714153 |
94 | CAMK2B | 0.49582318 |
95 | STK11 | 0.49108238 |
96 | PRKAA2 | 0.48530562 |
97 | CDK9 | 0.48513938 |
98 | CCNB1 | 0.48455963 |
99 | PRKAA1 | 0.47562498 |
100 | VRK2 | 0.46906458 |
101 | PRKD3 | 0.45565372 |
102 | GSK3B | 0.45190162 |
103 | WNK1 | 0.44764564 |
104 | EIF2AK2 | 0.44125191 |
105 | ERBB3 | 0.42746458 |
106 | PRKACA | 0.42083552 |
107 | MINK1 | 0.41710085 |
108 | PRKCG | 0.41619662 |
109 | PRKACG | 0.41093257 |
110 | WNK3 | 0.40780749 |
111 | TIE1 | 0.40533670 |
112 | MAPK9 | 0.39526925 |
113 | MAPK14 | 0.39427826 |
114 | RPS6KA3 | 0.39294390 |
115 | ROCK1 | 0.38749726 |
116 | PRKCH | 0.38464604 |
117 | MAPK15 | 0.37486909 |
118 | TXK | 0.37298545 |
119 | PRKD2 | 0.37242596 |
120 | PRKG1 | 0.36924585 |
121 | EPHA4 | 0.36631947 |
122 | ATR | 0.36162489 |
123 | TTK | 0.36016850 |
124 | CDK1 | 0.35796402 |
125 | PLK3 | 0.35318572 |
126 | PLK1 | 0.35212905 |
127 | MAPK10 | 0.34750993 |
128 | PIK3CA | 0.34105054 |
129 | MAP3K14 | 0.33993344 |
130 | GRK7 | 0.33789326 |
131 | MAP2K1 | 0.33325169 |
132 | CAMK4 | 0.33316924 |
133 | MAP2K4 | 0.32770869 |
134 | CAMK1 | 0.32661247 |
135 | PRKDC | 0.32501364 |
136 | CHEK2 | 0.32009908 |
137 | BRSK2 | 0.31824540 |
138 | STK38L | 0.31805863 |
139 | PRKCA | 0.30496323 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.69537183 |
2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31942416 |
3 | Phototransduction_Homo sapiens_hsa04744 | 15.0574342 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.83451140 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.77584163 |
6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62936837 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 1.56604983 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.49758852 |
9 | Protein export_Homo sapiens_hsa03060 | 1.47550310 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.45849675 |
11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44884221 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44346707 |
13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42105183 |
14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39602779 |
15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.33701350 |
16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.29475752 |
17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28315648 |
18 | Homologous recombination_Homo sapiens_hsa03440 | 1.26526697 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26477554 |
20 | Morphine addiction_Homo sapiens_hsa05032 | 1.25082999 |
21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23640131 |
22 | RNA polymerase_Homo sapiens_hsa03020 | 1.19125205 |
23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.18172431 |
24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16816603 |
25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16119004 |
26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.14183084 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12582156 |
28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.09885039 |
29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09396386 |
30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.06222211 |
31 | Peroxisome_Homo sapiens_hsa04146 | 1.05362586 |
32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04275552 |
33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02689808 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96412521 |
35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93783486 |
36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93224936 |
37 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91919326 |
38 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82541463 |
39 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80888087 |
40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80780531 |
41 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77443483 |
42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76288187 |
43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75283884 |
44 | Insulin secretion_Homo sapiens_hsa04911 | 0.74227440 |
45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73090669 |
46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68196875 |
47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66581992 |
48 | Taste transduction_Homo sapiens_hsa04742 | 0.64242859 |
49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63529590 |
50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61085051 |
51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59623907 |
52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58317445 |
53 | Cocaine addiction_Homo sapiens_hsa05030 | 0.55943247 |
54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54234285 |
55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53745567 |
56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52064411 |
57 | Axon guidance_Homo sapiens_hsa04360 | 0.51243275 |
58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50852948 |
59 | Purine metabolism_Homo sapiens_hsa00230 | 0.50822069 |
60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50410585 |
61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50200543 |
62 | ABC transporters_Homo sapiens_hsa02010 | 0.50114964 |
63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50064411 |
64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49751880 |
65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47368703 |
66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45801098 |
67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45331695 |
68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44943130 |
69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44567744 |
70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44441913 |
71 | Salivary secretion_Homo sapiens_hsa04970 | 0.44429066 |
72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43929361 |
73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43578382 |
74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43508954 |
75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41695022 |
76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41641919 |
77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40621263 |
78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38738028 |
79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38512266 |
80 | Renin secretion_Homo sapiens_hsa04924 | 0.37733731 |
81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37702432 |
82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37451219 |
83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37415304 |
84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37165509 |
85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36959738 |
86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36917567 |
87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36198384 |
88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36088480 |
89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36084168 |
90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35693640 |
91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34319367 |
92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.34290246 |
93 | Alcoholism_Homo sapiens_hsa05034 | 0.33642402 |
94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.33621367 |
95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33397944 |
96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33228667 |
97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32793648 |
98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32642560 |
99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32263336 |
100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31969606 |
101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30545113 |
102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30541459 |
103 | Gap junction_Homo sapiens_hsa04540 | 0.30285688 |
104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29520420 |
105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.27434534 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27376159 |
107 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27330340 |
108 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27305158 |
109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26992984 |
110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26466538 |
111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26301279 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25577364 |
113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25426862 |
114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25035374 |
115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24807714 |
116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23869890 |
117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23745248 |
118 | Lysine degradation_Homo sapiens_hsa00310 | 0.23709336 |
119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23574639 |
120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.23038475 |
121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.22723744 |
122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22586234 |
123 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.22392698 |
124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22306537 |
125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22156337 |
126 | Mineral absorption_Homo sapiens_hsa04978 | 0.22011284 |
127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21730762 |
128 | Long-term depression_Homo sapiens_hsa04730 | 0.21143824 |
129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20895257 |
130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19727071 |
131 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.18781560 |
132 | RNA degradation_Homo sapiens_hsa03018 | 0.18724131 |
133 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.18687244 |
134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.17895241 |
135 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.16907924 |
136 | Basal transcription factors_Homo sapiens_hsa03022 | 0.15773549 |
137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15455077 |
138 | Phagosome_Homo sapiens_hsa04145 | 0.15325715 |
139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14220553 |
140 | Melanogenesis_Homo sapiens_hsa04916 | 0.13774583 |
141 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.12544070 |
142 | Allograft rejection_Homo sapiens_hsa05330 | 0.12496700 |
143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.11974752 |
144 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11524843 |
145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10961038 |
146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.10188195 |